Procter & Gamble Health Limited (PGHL.BO)
Procter & Gamble Health Limited operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Mumbai, MA, IN. The stock last traded at $5933.70, up 0.19% on the session, giving a market capitalisation of $98.66B. Its beta of 0.20 implies it has historically moved less than the broad market.
Procter & Gamble Health Limited is engaged in the development, manufacturing, and global distribution of pharmaceuticals and chemical products, with operations both within India and across international markets. Its product range includes various over-the-counter medications, as well as essential vitamins, minerals, and dietary supplements. These offerings are sold under well-known brand names such as Cosome, Polybion, Neurobion, Evion, Nasivion, Livogen, and Seven Seas. Established in 1967, the company was previously known as Merck Limited before officially changing its name to Procter & Gamble Health Limited in May 2019. The firm's corporate headquarters are situated in Mumbai, India, and it operates as a subsidiary of Procter & Gamble Overseas India BV.
Procter & Gamble Health Limited is most often compared with the following Healthcare names: